GlassScriptPhysician profile
Kenneth S Chakour
NPI 1700148483
$98,100.75
in general payments reported to CMS, 2019-2025
21 companies · $22K in 2025
The $22K reported for 2025 was more than what 82% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,354 · 2020: $2,092 · 2021: $1,352 · 2022: $8,674 · 2023: $30K · 2024: $29K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $74K · Food and Beverage: $3,916 · Travel and Lodging: $2,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $74,050.43 |
| Food and Beverage | $3,916.04 |
| Travel and Lodging | $2,662.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $82,553.43 | 2019-2025 | Attune, Actis, Velys |
| Depuy Synthes Products, INC. | $7,121.43 | 2024-2025 | Attune, Velys |
| Stryker Corporation | $3,762.22 | 2019-2025 | Mako, Makoplasty |
| Depuy Synthes Sales INC. | $2,505.84 | 2019-2025 | Velys, Attune, Pinnacle |
| Zimmer Biomet Holdings, INC. | $1,371.83 | 2021-2025 | |
| Pacira Therapeutics, INC. | $176.19 | 2019 | |
| Exactech, INC. | $149.58 | 2019 | |
| Smith+Nephew, INC. | $122.24 | 2022-2025 | Real Intelligence, Journey II |
| Vertex Pharmaceuticals Incorporated | $85.32 | 2025 | |
| Heron Therapeutics, INC. | $42.01 | 2022 | |
| Solventum Corporation | $29.02 | 2024 | Prevena |
| Kci USA, INC. | $26.07 | 2023 | Prevena |
| Bioventus LLC | $24.56 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.43 | 2023 | Exparel, Iovera, Zilretta |
| Dynasplint Systems INC. | $18.33 | 2023 | Dynasplint |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $18.06 | 2022 | |
| Curonix LLC | $17.18 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kowa Pharmaceuticals America, INC. | $15.75 | 2023 | Seglentis |
| Ferring Pharmaceuticals INC. | $15.68 | 2019 | |
| Fidia Pharma USA INC. | $14.36 | 2022 | |
| Mallinckrodt Enterprises LLC | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Chakour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.